mhealth in diagnostics
TRANSCRIPT
John BannisterGlobal Health Regional Sales [email protected]
TITLE
VISITECT® CD4 PoC Smartphone App
mHealth Solutions
Founded in 2004, Omega Diagnostics Group PLC is focused on selling a wide range of specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market within three segments: Allergy and Autoimmune, Food Intolerance and Infectious Disease.
To improve human health and well-being through innovative diagnostic tests and global partnerships
Our Mission
100+ Countries
• Over 25 years experience of manufacturing and exporting IVD diagnostics products to over 100 countries including many with resource limited facilities.
• VISITECT® CD4 developed in partnership with the Burnet Institute (Melbourne, Aus) with funding provided by the Bill & Melinda Gates Foundation
• Android Smartphone App developed on Samsung platform for reading, interpretation and reporting VISITECT® CD4 POC
• RDT pipeline is mHealth orientated
Partnerships
